Found: 34
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. i, doi. 10.1111/apt.18035
- Publication type:
- Article
Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S10, doi. 10.1111/apt.17930
- By:
- Publication type:
- Article
Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S23, doi. 10.1111/apt.17866
- By:
- Publication type:
- Article
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S1, doi. 10.1111/apt.17833
- By:
- Publication type:
- Article
Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S52, doi. 10.1111/apt.17848
- By:
- Publication type:
- Article
Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S41, doi. 10.1111/apt.17752
- By:
- Publication type:
- Article
Editorial: Bile acid diarrhoea – simplified clinico‐biochemical diagnosis.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 122, doi. 10.1111/apt.17771
- By:
- Publication type:
- Article
Meta‐analysis: Impact of intragastric balloon therapy on NAFLD‐related parameters in patients with obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 8, doi. 10.1111/apt.17805
- By:
- Publication type:
- Article
Editorial: Is there a relationship between dysphagia, chest pain and mucosal innervation in patients with oesophageal motility disorders?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Editorial: Moving towards prognostic endoscopic scoring in IBD.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: 'No first among equals'—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 145, doi. 10.1111/apt.17806
- By:
- Publication type:
- Article
A Message from the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 4, doi. 10.1111/apt.17797
- By:
- Publication type:
- Article
AP&T: Editors' declarations of interest.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 6, doi. 10.1111/apt.17799
- Publication type:
- Article
Letter: Comparing first‐line infliximab and vedolizumab for ulcerative colitis—it depends on how you use the drug. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 142, doi. 10.1111/apt.17796
- By:
- Publication type:
- Article
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Letter: 'No first among equals'.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 144, doi. 10.1111/apt.17792
- By:
- Publication type:
- Article
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 138, doi. 10.1111/apt.17788
- By:
- Publication type:
- Article
Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 23, doi. 10.1111/apt.17748
- By:
- Publication type:
- Article
Editorial: Antibiotics as a risk factor for irritable bowel syndrome.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Superficial oesophageal mucosal innervation may contribute to severity of symptoms in oesophageal motility disorders.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 100, doi. 10.1111/apt.17773
- By:
- Publication type:
- Article
Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis. Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 80, doi. 10.1111/apt.17783
- By:
- Publication type:
- Article
Letter: Comparing first‐line infliximab and vedolizumab for ulcerative colitis—it depends on how you use the drug.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 140, doi. 10.1111/apt.17770
- By:
- Publication type:
- Article
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 89, doi. 10.1111/apt.17777
- By:
- Publication type:
- Article
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Obeticholic acid as a second‐line treatment for low phospholipid‐associated cholelithiasis syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 113, doi. 10.1111/apt.17761
- By:
- Publication type:
- Article
Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 71, doi. 10.1111/apt.17756
- By:
- Publication type:
- Article
Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 136, doi. 10.1111/apt.17767
- By:
- Publication type:
- Article
Prospective comparison of diagnostic tests for bile acid diarrhoea.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 39, doi. 10.1111/apt.17739
- By:
- Publication type:
- Article
The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long‐term clinical outcomes in patients with ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 64, doi. 10.1111/apt.17753
- By:
- Publication type:
- Article
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 51, doi. 10.1111/apt.17734
- By:
- Publication type:
- Article
Editorial: Resmetirom – a promising treatment option for NASH and liver fibrosis.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. 1, doi. 10.1111/apt.17572
- Publication type:
- Article